About: Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 August 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в серпні 2008 (uk) scientific article published on 05 August 2008 (en) مقالة علمية نشرت في 05 أغسطس 2008 (ar)
publication date	wds:Q37235854-0DB5CC3B-920D-444A-AC38-2BC40E6589BF
publication date	2008-08-05 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37235854-4A23FE33-6C00-49FD-97F9-73DB56D01CCC
language of work or name	English
cites work	wds:Q37235854-078DF622-6A02-4EE4-BB5D-BC3060442A2E wds:Q37235854-0845E1D9-DEA3-4582-8A9C-5559802F61FA wds:Q37235854-0A1ECDC0-AB5A-4945-8D4C-3200C78ADEDD wds:Q37235854-10F31A74-5967-4A51-9DEE-F3680A004BD3 wds:Q37235854-2C9A916D-58EC-4EC5-848F-C4AD39200C0F wds:Q37235854-368D001E-742E-4B29-91D6-B016A448BFD1 wds:Q37235854-3F03AF0C-5E9B-42ED-89B4-0C0BF5B3403B wds:Q37235854-5DC418DF-6F29-4932-988C-123C6231E4E3 wds:Q37235854-63997042-1531-40C0-8167-5BB371C4112B wds:Q37235854-7E77FE11-6441-4E57-B06D-56550DFDBC37 wds:Q37235854-80E0FB72-98A4-45CD-B7E3-35785EF00600 wds:Q37235854-82AEE972-0BAB-4C66-8600-3F370FEB7CB7 wds:Q37235854-8C92C047-4627-44F2-BACE-293944BA0AB8 wds:Q37235854-8D13C84A-B249-416C-B75E-80A55BEBE466 wds:Q37235854-97A3917C-2506-41ED-878E-D1C1B319D10A wds:Q37235854-A8DD2FDA-C08C-4E53-A4ED-A752AF76454B wds:Q37235854-CD022F31-265C-476A-9D36-F64DD6D20590 wds:Q37235854-DA497E5B-D3F4-44A5-A74C-EA2F9721EC1E wds:Q37235854-DDC294B4-FA68-42FB-BE17-96DF12CB23B2
cites work	The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy Operating characteristics of a rank correlation test for publication bias Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting Development of a pharmacist-managed lipid clinic Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia Achieving cholesterol target in a managed care organization (ACTION) trial The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus). Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease.
author name string	wds:Q37235854-4296FA50-A3A5-4741-8EB5-63B65F18C9C6 wds:Q37235854-61075C97-A065-47ED-8FE9-FB6B50087D3D wds:Q37235854-CDF8C58B-1079-4644-ABD4-919D2FF0478A wds:Q37235854-CEEBB02A-11AB-4F90-95E5-556439B4E53F wds:Q37235854-E192083D-2B82-4DC8-B6A7-56F76F7B5D20
author name string	Márcio Machado Thomas R Einarson Giovanni C Guzzo Jana M Bajcar Nermine Nassor
rdfs:label	Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (en) Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (nl) Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (ast)
skos:prefLabel	Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (en) Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (nl) Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (ast)
name	Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (en) Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (nl) Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (ast)
title	wds:Q37235854-629D1E0B-5AE9-4A3F-A51D-971309C882D7
title	Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management (en)
page(s)	wds:Q37235854-1C1241A9-B8E4-435E-B60A-1593D110BF50
page(s)	1195-1207
instance of	wds:Q37235854-3252cb14-162b-4b2b-a979-7f1455338074 wds:Q37235854-81744ED4-E9AF-40A5-949B-6D95E350F070 wds:Q37235854-f31a6fea-1482-47c5-889d-c262048e2276
instance of	meta-analysis review article scholarly article
main subject	wds:Q37235854-652C13E8-BF1A-405D-BBBC-ED72A6AA958E wds:Q37235854-A0B00B8E-C1D3-4BE1-83BE-2E50FB0A6700 wds:Q37235854-A9A8BA6D-5B58-4802-921E-491C62318928 wds:Q37235854-D83246BE-0080-4E0E-9E91-C2C0FE6C85E0
main subject	hyperlipidemia meta-analysis Patients systematic review
PubMed ID	wds:Q37235854-A6D9CC14-1EB7-4A7C-A75C-E708F46FF222
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18682540
PubMed ID	18682540
published in	wds:Q37235854-8C6388F3-96A0-4270-ADF0-CE18B7E25B43

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software